Home - Translational Lung Cancer Research

New Impact Factor for Translational Lung Cancer Research: 3.5

We are pleased to announce that the Translational Lung Cancer Research (TLCR) has attained its latest impact factor update for the 2024 citation year: 3.5.

Translational Lung Cancer Research 2024 CiteScore Released: 6.9

We are pleased to announce that the Translational Lung Cancer Research (TLCR) has achieved its 2024 CiteScore: 6.9, ranking 92 out of 415 journals in the Oncology category. This milestone underscores our ongoing commitment to publishing impactful research in the field.

Interviews with Outstanding Authors (2025)

In 2025, many authors make outstanding contributions to our journal. Their articles published with us have received very well feedback in the field and stimulate a lot of discussions and new insights among the peers.

Hereby, we would like to highlight some of our outstanding authors, with a brief interview of their thoughts and insights as authors. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

Reviewer of the Month (2025)

In 2025, TLCR reviewers continue to make outstanding contributions to the peer review process. They demonstrated professional effort and enthusiasm in their reviews and provided comments that genuinely help the authors to enhance their work.

Hereby, we would like to highlight some of our outstanding reviewers, with a brief interview of their thoughts and insights as a reviewer. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

TLCR Annual Report 2024

Welcome to the 2024 annual report for Translational Lung Cancer Research. In 2024, the TLCR has continued its mission to increase the quality and impact of the journal, and to provide readers with a novel, well-organized, informative, enlightening and educational journal.

We would like to sincerely thank our Editorial Board Members, Guest editors, Reviewers, Authors, Readers for all your supports and contributions to TLCR in 2024, and we look forward to continuing our work with you in the new year.

Interviews with Editorial Board Members

TLCR features a distinguished editorial board, the members of which continue to instill the power of their expertise for the journal’s development. By launching this column, we are glad to introduce to you some of them in the form of interviews, in which they will share their unique career experiences and perspectives. We believe their insights will shed light on the knowledge of related fields.

Interviews with Guest Editors

Over the years, a number of TLCR guest editors have made valuable contributions to the journal. This column features interviews with our guest editors, who graciously share their experience in scientific careers and provide insightful perspectives on the special series.

‹ ›

Vol 14, No 6 (June, 2025)

Articles in Press

Past Issues

About tlcr

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

General editorial enquiries:
Email: editor@tlcr.org
Copyright related contact:
Email: permissions@amegroups.com
Commercial Sales contact (Reprints, advertising, etc.):
Email: sales@amegroups.com

Editorial

Redefining the role of surgery in advanced lung cancer: a new paradigm of adjuvant lung surgery to systemic therapy

Ran Zhong, Junguo Dong, Hengrui Liang, Jianxing He

PDF Pages: 1892-1895 Full Text (24) Peer Review File COI Form Open Access

Original Article

Cytokine-driven modulation of WT1 and IL-10 in lung cancer progression

Juan Manuel Izaguirre-Alvarez, Pablo Zapata-Benavides, Mariela Arellano-Rodríguez, Norma Cesilia Arellano-Rodríguez, Felipe-de-Jesús Torres-Del-Muro, Moisés Armides Franco-Molina, María Cristina Rodríguez-Padilla

PDF Pages: 1896-1913 Full Text (29) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Impact of KRAS mutation subtypes on morphological heterogeneity and immune landscape in surgically treated lung adenocarcinoma

Klara Torok, Bence Ferencz, Kristiina Boettiger, Maria Dorothea Pozonec, Orsolya Pipek, Julianna Bogos, Andras Lantos, Zita Hegedus, Karin Schelch, Peter Radeczky, Krisztina Bogos, Vivien Teglas, Evelyn Megyesfalvi, Anita Ferenczy, Ferenc Renyi-Vamos, Clemens Aigner, Zsolt Megyesfalvi, Balazs Dome, Janos Fillinger

PDF Pages: 1914-1928 Full Text (39) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Development and validation of growth prediction models for multiple pulmonary ground-glass nodules based on CT features, radiomics, and deep learning

Shulei Cui, Linlin Qi, Weixiong Tan, Yujian Wang, Fenglan Li, Jianing Liu, Jiaqi Chen, Sainan Cheng, Zhen Zhou, Jianwei Wang

PDF Pages: 1929-1944 Full Text (24) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Monitoring pembrolizumab response in patients with metastatic non-small cell lung cancer using circulating tumour DNA and circulating tumour cells

Andrea C. Kakouri, Maria Spiliotaki, Eleni M. Loizidou, Ioannis Stylianou, Elisavet Papageorgiou, Christina G. Panayi, Andreas I. Constantinou, Haris Charalambous, Constantinos Deltas, Gregory Papagregoriou

PDF Pages: 1945-1960 Full Text (29) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Evaluation of gut leakage and bacterial translocation as efficacy biomarkers of immunotherapy in advanced non-small cell lung cancer (NSCLC)

Pierre Magdelaine, Adrien Costantini, Paul Takam Kamga, Christy Gaella Kotokpo Youkou, Jennifer Arrondeau, Marie Wislez, Jean-François Emile, Etienne Giroux-Leprieur

PDF Pages: 1961-1971 Full Text (18) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Predictors of survival and recurrence patterns following definitive chemoradiotherapy in stage III non-small cell lung cancer—a retrospective cohort study

Erika Broström, Johan Isaksson, Panagiotis Xanthoulis, Rebecka Börjesson, Linda Willén, Tomas Hansen, Georg Holgersson, Simon Ekman, Johan Botling, Kristina Lamberg Lundström, Patrick Micke, Magnus Lindskog

PDF Pages: 1972-1985 Full Text (13) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Utility of serum CYFRA 21-1 as a prognostic biomarker in ALK-positive non-small cell lung cancer treated with ALK-TKIs: a retrospective cohort study

Ryo Sawada, Tadaaki Yamada, Yasuhiro Goto, Yoshiki Negi, Akira Nakao, Akihiro Yoshimura, Naoki Furuya, Tomohiro Oba, Makoto Hibino, Haruka Nakatani, Hirokazu Taniguchi, Aya Ohtsubo, Satoshi Watanabe, Takahiro Yamada, Yusuke Chihara, Takashi Kijima, Koichi Takayama

PDF Pages: 1986-2000 Full Text (25) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Impact of mutant protein expression on clinical outcomes in patients with EGFR L858R-mutated non-small cell lung cancer

Ryota Nakamura, Tadaaki Yamada, Kenji Morimoto, Akihiro Yoshimura, Shinsuke Shiotsu, Nozomu Motono, Hidetaka Uramoto, Tatsuya Imabayashi, Yoshizumi Takemura, Yuki Katayama, Naoya Nishioka, Masahiro Iwasaku, Shinsaku Tokuda, Satoru Okada, Masanori Shimomura, Masayoshi Inoue, Noriyuki Tanaka, Aya Miyagawa-Hayashino, Koichi Takayama

PDF Pages: 2001-2010 Full Text (19) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

An explainable AI approach to surgical and radiotherapy interventions for optimized treatment decision-making in early-stage non-small cell lung cancer

Qunzhe Ding, Chendong Wang, Zhe Zhang, Junjie Liao, Lufan Tang, Jiade Jay Lu, Zhibo Tan

PDF Pages: 2011-2030 Full Text (15) Reporting Checklist Peer Review File COI Form Open Access

A retrospective real-world single-arm study evaluating the efficacy and safety of neoadjuvant chemotherapy in patients with selected limited-stage small-cell lung cancer

Wengang Zhang, Yujie Li, Jing Nie, Wencheng Zhao, Zhiyi Guo, Shunjia Li, Qianqian Zhang, Bing Bo, Xuyang Chen, Li Ye, Zhimin Chen, Hao Wang, Kandi Xu, Lishu Zhao, Xinyue Liu, Yujin Liu, Yuhang Li, Lihua Huang, Yayi He

PDF Pages: 2031-2046 Full Text (24) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Assessing the clinical impact of severe lung cancer on non-small cell lung cancer: a single-center retrospective study

Huixin Jiang, Ling Yi, Du Feng, Hao Deng, Qiexinhao Li, Wenhui Guan, Yue Zhu, Yijia Li, Bin He, Gengda Huang, Ying Wu, Xinqing Lin, Chengzhi Zhou

PDF Pages: 2047-2061 Full Text (17) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Response of non-small cell lung cancer harboring different epidermal growth factor receptor mutations to ablative radiotherapy

Areej Al Rabea, Ian J. Gerard, Paul Daniel, Sophie Camilleri-Broët, Ayman Oweida, Siham Sabri, Bassam Abdulkarim

PDF Pages: 2062-2073 Full Text (11) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

The effect of durvalumab consolidation after definitive radiochemotherapy for non-operable stage III non-small cell lung cancer on the dose effect relation for therapy related pulmonary infiltrates as a risk factor for pneumonitis

Andreas Herz, Maja Guberina, Christoph Pöttgen, Thomas Gauler, That Truong Mike Ton, Gerrit Fischedick, Lars Oliver Kiwitt, Wolfgang Lübcke, Christian Hoffmann, Martin Schuler, Martin Metzenmacher, Benedikt M. Schaarschmidt, Denise Bos, Marcel Opitz, Hubertus Hautzel, Kaid Darwiche, Servet Bölükbas, Konstantinos Grapatsas, Verena Jendrossek, Lena Gockeln, Florian Wirsdörfer, Mario Hetzel, Emil Mladenov, Martin Stuschke, Nika Guberina

PDF Pages: 2074-2088 Full Text (17) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Radiographic ground-glass nodules predict less aggressive features and favorable immune landscapes in early lung adenocarcinoma and its precursors

Runzhe Chen, Mingdian Wang, Qi Quan, Dijian Shen, Qiong Li, Xiujiao Shen, Xuan Li, Ming Chen

PDF Pages: 2089-2099 Full Text (11) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Utility of CK8/18 in identifying circulating tumor cells derived from lesions in patients with non-small cell lung cancer

Tetsuya Sakai, Mami Onishi, Yoshitaka Zenke, Eri Morita Yamamoto, Yuichi Ijiri, Kana Kawasaki, Fumie Kato, Tomoko Sugano, Bishnu Devi Maharjan, Ali Asgar S. Bhagat, Tomokazu Yoshida, Shigeki Iwanaga, Masatoshi Yanagida, Koichi Goto

PDF Pages: 2100-2112 Full Text (13) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Serum levels of C-terminal peptides of alpha-1 antitrypsin as potential biomarkers in non-small cell lung cancer

Marc A. Schneider, Friedemann R. Boerner, Michael Kiehntopf, Thomas Muley, Sabina Janciauskiene

PDF Pages: 2113-2124 Full Text (16) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Identification of prognostic-related tumor microenvironment genes in lung adenocarcinoma and establishment of a prognostic prediction model

Xisheng Fang, Shaopeng Zheng, Zekui Fang, Xiping Wu, Erin L. Schenk, Lorenzo Belluomini, Huizhen Fan

PDF Pages: 2125-2144 Full Text (20) Reporting Checklist Peer Review File COI Form Open Access

Enhancing the intraoperative identification of high-grade patterns in invasive lung adenocarcinoma via radiomics

Yuanxin Sun, Hao Dong, Weiqiu Jin, Haoxiang Xuan, Zheng Yuan, Lukas Käsmann, Leilei Shen, Tingting Wang, Xiaodan Ye, Mengsu Zeng

PDF Pages: 2145-2158 Full Text (28) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Development of a 3D-3 co-culture microbead consisting of cancer-associated fibroblasts and human umbilical vein endothelial cells for the anti-tumor drug assessment of lung cancer

Shuisheng Chen, Wei Chen, Ziyun Guan, Luwen Lei, Yiyan Lei, Kejing Tang, Xiao Chen, Robert Hsu, Yong Dong, Yubo Tang

PDF Pages: 2159-2179 Full Text (19) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Natural course of lung adenocarcinoma manifesting as ground-glass nodules: invasiveness assessment based on growth evaluation

Yuanhui Wei, Zhen Yang, Zirui Wang, Jiabo Ren, Yue Yin, Shangshu Liu, Xiaoyan Su, Sara Ricciardi, Takehiro Izumo, Wei Zhao, Liang-An Chen

PDF Pages: 2180-2196 Full Text (12) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Efficacy of immunotherapy in advanced ALK-rearranged non-small cell lung cancer patients with disease progression on ALK-TKIs

Danni Wang, Yujing Li, Beibei Liu, Yuqing Lou, Lele Zhang, Yueran Sun, Fangfei Qian, Jun Lu, Fusheng Li, Edyta M. Urbanska, Diego Kauffmann-Guerrero, Xinwei Wu, Baohui Han, Yanwei Zhang, Wei Zhang

PDF Pages: 2197-2209 Full Text (22) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Endoplasmic reticulum stress-related genes contribute to lung cancer risk: a multiomics data integration study

Zhaoxun Li, Suqin Wang, Zhen Yang, Fujun Yang, Jiayan Tan, Yaqin Wei, Esteban C. Gabazza, Mariacarmela Santarpia, Yimu Wu, Gening Jiang, Ya Li

PDF Pages: 2210-2226 Full Text (22) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Surgical treatment of small-cell lung cancer: long-term prognosis and patterns of adjuvant therapy

Ruichen Cui, Xiaohu Hao, Jiahan Cheng, Jacobo Rogado, Qiang Pu, Yunke Zhu

PDF Pages: 2227-2238 Full Text (13) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Fructose-diphosphate aldolase C as a novel diagnostic biomarker for early-stage non-small cell lung cancer: a low-abundance proteomics study

Changsen Bai, Qianhui Hao, Yunxiang Chen, Jiayi Wang, Jiawei Xiao, Da Hyun Kang, Li Ren

PDF Pages: 2239-2256 Full Text (12) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Review Article

Towards the development of next-generation lung cancer immunotherapy

Yoshinobu Ichiki, Nako Saito, Ryo Taguchi, Tetsuya Umesaki, Hiroyuki Nitanda, Hirozo Sakaguchi, Hironori Ishida, Tomonori Kawasaki, Hisao Imai, Kyoichi Kaira, Hiroshi Kagamu

PDF Pages: 2257-2271 Full Text (10) Peer Review File COI Form Open Access

Research progress on lung cancer complicated with pulmonary tuberculosis: a narrative review

Ze-Jun Zhou, Hai-Yan Xie, Luca Bertolaccini, Ning Xia, Yu Zhang

PDF Pages: 2272-2280 Full Text (11) Reporting Checklist Peer Review File COI Form Open Access

Traditional Chinese medicine in the prevention and treatment of lung cancer metastasis by regulating tumor-associated macrophages: a narrative review

Xinyi Tu, Baozhen An, Haolong Qi, Na Zhang, Yanqiu Liu

PDF Pages: 2281-2295 Full Text (23) Reporting Checklist Peer Review File COI Form Open Access

Comorbidity of lung cancer and chronic obstructive pulmonary disease: correlation and optimization of treatment strategies

Huixin Jiang, Gengda Huang, Du Feng, Till Plönes, Robert P. Young, Ramin Salehi-Rad, Qibo Liu, Ying Meng, Chengzhi Zhou

PDF Pages: 2296-2308 Full Text (9) Peer Review File COI Form Open Access

Brief Report

Safety and efficacy of thermal ablation for small cell lung cancer liver metastases

Shunn Theingi, Ashara Mitchell, Elena N. Petre, Etay Ziv, Constantinos T. Sofocleous, Stephen B. Solomon, Erica S. Alexander

PDF Pages: 2309-2316 Full Text (12) Reporting Checklist Peer Review File COI Form Open Access

Case Report

Needle tract seeding after endobronchial ultrasound-guided intranodal forceps biopsy and cryobiopsy: a case report

Kohei Yamamoto, Tatsuya Imabayashi, Yukari Kano, Toshiyuki Tanaka, Kazuki Jinno, Shunya Tanaka, Sayaka Uda, Tatsuya Yuba, Chieko Takumi

PDF Pages: 2317-2323 Full Text (11) Reporting Checklist Peer Review File COI Form Open Access

Liquid biopsy perspectives in pleomorphic carcinoma of the lung: case report

Tania Rossi, Michela Cortesi, Michele Zanoni, Sara Bandini, Camilla Sbrighi, Davide Angeli, Valentina Masciale, Giulia Grisendi, Matteo Costantini, Franco Stella, Paola Ulivi, Beatrice Aramini

PDF Pages: 2324-2336 Full Text (11) Reporting Checklist Peer Review File COI Form Open Access

Good response to first-line immunotherapy-based treatment in lung squamous carcinoma with rare driver gene mutations: a report of three cases

Li Tu, Yanyang Liu, Xiaoming Qiu, Jiewei Liu

PDF Pages: 2337-2346 Full Text (10) Reporting Checklist Peer Review File COI Form Open Access

Editorial Commentary

Paving the way for ctDNA-guided trials in lung cancer: insights from the LIBELULE study

Jose Carlos Benitez, Antonio Rueda-Domínguez

PDF Pages: 2347-2352 Full Text (10) Peer Review File COI Form Open Access

Long-term efficacy and improved overall survival of lorlatinib in anaplastic lymphoma kinase-rearranged lung cancer: is cure a dream or a reality?

Yoshitsugu Horio, Hiroaki Kuroda, Eiichi Sasaki, Katsuhiro Masago

PDF Pages: 2353-2358 Full Text (12) Peer Review File COI Form Open Access

Review Articles

Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?

Yoshihisa Kobayashi, Tetsuya Mitsudomi

Published online: 22 October 2013

PDF Pages: 354-363 Full Text (338601) Open Access

Editorial Commentary

Ground glass nodules with 5 years’ stability can grow after 10-year follow-up: do genetic features determine the fate?

Yoshihisa Kobayashi, Tetsuya Mitsudomi

Published online: 31 December 2019

PDF Pages: S425-S427 Full Text (85331) Open Access

Review Article

Non-small cell lung cancer: current treatment and future advances

Cecilia Zappa, Shaker A. Mousa

Published online: 30 June 2016

PDF Pages: 288-300 Full Text (77955) Open Access

Review Articles

Irreversible EGFR-TKIs: dreaming perfection

Lorenza Landi, Federico Cappuzzo

Published online: 14 January 2013

PDF Pages: 40-49 Full Text (70205) Open Access

Review Article

Pulmonary ground-glass opacity: computed tomography features, histopathology and molecular pathology

Jian-Wei Gao, Stefania Rizzo, Li-Hong Ma, Xiang-Yu Qiu, Arne Warth, Nobuhiko Seki, Mizue Hasegawa, Jia-Wei Zou, Qian Li, Marco Femia, Tang-Feng Lv, Yong Song, written on behalf of the AME Lung Cancer Collaborative Group

Published online: 28 February 2017

PDF Pages: 68-75 Full Text (59842) Open Access

Review Article

Recurrence after surgery in patients with NSCLC

Hidetaka Uramoto, Fumihiro Tanaka

Published online: 28 August 2014

PDF Pages: 242-249 Full Text (47578) Open Access

Review Article

Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatment

Tianli Zhang, Bing Wan, Yuan Zhao, Chuling Li, Hongbing Liu, Tangfeng Lv, Ping Zhan, Yong Song

Published online: 30 June 2019

PDF Pages: 302-316 Full Text (43114) Open Access

Review Article

Targeted therapy for non-small cell lung cancer: current standards and the promise of the future

Bryan A. Chan, Brett G.M. Hughes

Published online: 24 February 2015

PDF Pages: 36-54 Full Text (43194) Open Access

Review Article

Lung cancer prediction using machine learning and advanced imaging techniques

Timor Kadir, Fergus Gleeson

Published online: 14 June 2018

PDF Pages: 304-312 Full Text (42890) Open Access

Review Article

The past, present and future of immunotherapy against tumor

Tao Jiang, Caicun Zhou

Published online: 24 June 2015

PDF Pages: 253-264 Full Text (39471) Open Access

Review Article

Ground-glass nodules of the lung in never-smokers and smokers: clinical and genetic insights

Yoshihisa Kobayashi, Chiara Ambrogio, Tetsuya Mitsudomi

Published online: 28 August 2018

PDF Pages: 487-497 Full Text (38131) Chinese (5495) Open Access

Review Article

The epidemiology of lung cancer

Patricia M. de Groot, Carol C. Wu, Brett W. Carter, Reginald F. Munden

Published online: 14 June 2018

PDF Pages: 220-233 Full Text (34057) Open Access

Review Article

Lung cancer screening: nodule identification and characterization

Ioannis Vlahos, Konstantinos Stefanidis, Sarah Sheard, Arjun Nair, Charles Sayer, Joanne Moser

Published online: 14 June 2018

PDF Pages: 288-303 Full Text (33146) Open Access

Review Articles

KRAS mutant NSCLC, a new opportunity for the synthetic lethality therapeutic approach

Javier de Castro Carpeño, Cristóbal Belda-Iniesta

Published online: 03 April 2013

PDF Pages: 142-151 Full Text (32391) Open Access

Review Article on Update on Pathology and Predictive Biomarkers of Lung Cancer

Biology of invasive mucinous adenocarcinoma of the lung

Yoon Jin Cha, Hyo Sup Shim

Published online: 11 October 2017

PDF Pages: 508-512 Full Text (32119) Open Access

Review Article

Molecular testing strategies in non-small cell lung cancer: optimizing the diagnostic journey

Jeffrey P. Gregg, Tianhong Li, Ken Y. Yoneda

Published online: 30 June 2019

PDF Pages: 286-301 Full Text (32120) Open Access

Consensus

Tubeless video-assisted thoracic surgery for pulmonary ground-glass nodules: expert consensus and protocol (Guangzhou)

Jianxing He, Hengrui Liang, Wei Wang, Andrey Akopov, Alberto Aiolfi, Keng-Leong Ang, Luca Bertolaccini, Kaican Cai, Qingdong Cao, Baojun Chen, Chang Chen, Chun Chen, Donglai Chen, Fengxia Chen, Jun Chen, Lei Chen, Mingwu Chen, Yongbing Chen, Zhuxing Chen, Chao Cheng, Dong Cui, Fei Cui, Tianyang Dai, Qinglong Dong, Paolo A. Ferrari, Raja M. Flores, Junke Fu, Soichiro Funaki, Marios E. Froudarakis, Xiangfeng Gan, Mingfei Geng, Jialong Guo, Qiang Guo, Yongtao Han, Jintao He, Kaiming He, Kyoji Hirai, Jian Hu, Shuqiao Hu, Jian Huang, Jun Huang, Wenfa Jiang, Kyung Soo Kim, Gabor Kiss, Fanyi Kong, Lan Lan, Xuefeng Leng, Bin Li, Gaofeng Li, Hecheng Li, Hefei Li, Heng Li, Jiwei Li, Xiaoqiang Li, Shuben Li, Yinfen Li, Zhuoyi Li, Yi Liang, Lixia Liang, Wenhua Liang, Yongde Liao, Wanli Lin, Xu Lin, Hongxu Liu, Hui Liu, Jixian Liu, Jun Liu, Xiang Liu, Zihao Liu, Xingzhao Lu, Qingquan Luo, Naiquan Mao, Qi Pan, Dazhi Pang, Jun Peng, Jun Peng, Eugenio Pompeo, Rulin Qian, Kun Qiao, Bassam Redwan, Zi Sang, Wenlong Shao, Jianfei Shen, Weiyu Shen, Sook-Whan Sung, Wenfang Tang, Tianhu Wang, Guangsuo Wang, Haitao Wang, Huien Wang, Jiyong Wang, Wen Wang, Yongyong Wang, Zhenyuan Wang, Li Wei, Wei Wei, Hao Wu, Jie Wu, Zhaohua Xia, Chenyang Xu, Enwu Xu, Hai Xu, Ning Xu, Quan Xu, Rongyu Xu, Shun Xu, Chaokun Yang, Hanyu Yang, Shengli Yang, Jun Yi, Guangjian Zhang, Hao Zhang, Jia Zhang, Man Zhang, Xiao Zhang, Yajie Zhang, Zhe Zhang, Zhifeng Zhang, Honglin Zhao, Jian Zhao, Xiaodong Zhao, Jianping Zhou, Yanran Zhou, Chengchu Zhu, Shaojin Zhu, Xinhai Zhu, Jian Cui, Yubo Yan, Ke-Neng Chen

Published online: 28 August 2021

PDF Pages: 3503-3519 Full Text (30363) COI Form Open Access

Review Article

Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer

Takashi Kohno, Takashi Nakaoku, Koji Tsuta, Katsuya Tsuchihara, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto

Published online: 19 April 2015

PDF Pages: 156-164 Full Text (29367) Open Access

Review Articles

New TNM classification: achievements and hurdles

Peter Goldstraw

Published online: 17 August 2013

PDF Pages: 264-272 Full Text (28946) Open Access

Review Articles

Angiogenesis in cancer: anti-VEGF escape mechanisms

Gerald W. Prager, Marina Poettler, Matthias Unseld, Christoph C. Zielinski

Published online: 18 February 2012

PDF Pages: 14-25 Full Text (28836) Open Access

Full Most Read article list >>

Original Article

Prognostic value of Twist in lung cancer: systematic review and meta-analysis

Junli Zeng, Ping Zhan, Guannan Wu, Wen Yang, Wenjun Liang, Tangfeng Lv, Yong Song

BRAF mutations in non-small cell lung cancer

Peter P. Luk, Bing Yu, Chiu Chin Ng, Belinda Mercorella, Christina Selinger, Trina Lum, Steven Kao, Sandra A. O’Toole, Wendy A. Cooper

The suitability of small biopsy and cytology specimens for EGFR and other mutation testing in non-small cell lung cancer

Shu Wang, Bing Yu, Chiu Chin Ng, Belinda Mercorella, Christina I. Selinger, Sandra A. O’Toole, Wendy A. Cooper

Itraconazole can inhibit malignant pleural effusion by suppressing lymphangiogenesis in mice

Yunfen Wang, Yanwen Yao, Hongbin Liu, Xingqun Ma, Tangfeng Lv, Dongmei Yuan, Xinwu Xiao, Jie Yin, Yong Song

Ratio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer

Fangfang Chen, Yanwen Yao, Chunyan Ma, Xingqun Ma, Zhaofeng Wang, Tangfeng Lv, Xinwu Xiao, Jie Yin, Yong Song

Advanced proton beam dosimetry part II: Monte Carlo vs. pencil beam-based planning for lung cancer

Dominic Maes, Jatinder Saini, Jing Zeng, Ramesh Rengan, Tony Wong, Stephen R. Bowen

The cytokinesis-blocked micronucleus assay as a novel biomarker for selection of lung cancer screening participants

Randa A. El-Zein, Carol J. Etzel, Reginald F. Munden

The use of TCP based EUD to rank and compare lung radiotherapy plans: in-silico study to evaluate the correlation between TCP with physical quality indices

Abdulhamid Chaikh, Jacques Balosso

Review Article

Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer

Takashi Kohno, Takashi Nakaoku, Koji Tsuta, Katsuya Tsuchihara, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto

Overview of clinicopathologic features of ALK-rearranged lung adenocarcinoma and current diagnostic testing for ALK rearrangement

Hyojin Kim, Jin-Haeng Chung

Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer

Haoran Zhai, Wenzhao Zhong, Xuening Yang, Yi-Long Wu

Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations—a review

Erin L. Stewart, Samuel Zhixing Tan, Geoffrey Liu, Ming-Sound Tsao

Clinical trials for lung cancer in China

Fei-Yu Niu, Wen-Zhao Zhong, Qing Zhou, Yi-Long Wu

Recurrence after surgery in patients with NSCLC

Hidetaka Uramoto, Fumihiro Tanaka

Prognostic markers in lung cancer: is it ready for prime time?

Chang-Qi Zhu, Ming-Sound Tsao

Potential biomarkers for lung cancer screening

Gabriella Sozzi, Mattia Boeri

Particle therapy in non-small cell lung cancer

Zhongxing Liao, Charles B. Simone II

Computer Aided Nodule Analysis and Risk Yield (CANARY) characterization of adenocarcinoma: radiologic biopsy, risk stratification and future directions

Ryan Clay, Srinivasan Rajagopalan, Ronald Karwoski, Fabien Maldonado, Tobias Peikert, Brian Bartholmai

Immunotherapy and radiation therapy for operable early stage and locally advanced non-small cell lung cancer

Neil K. Taunk, Andreas Rimner, Melissa Culligan, Joseph S. Friedberg, Julie Brahmer, Jamie Chaft

Combining immunotherapy and radiation therapy for small cell lung cancer and thymic tumors

Suchit H. Patel, Andreas Rimner, Roger B. Cohen

Intraoperative near-infrared imaging of mesothelioma

Gregory Thomas Kennedy, Andrew Newton, Jarrod Predina, Sunil Singhal

BAP1, a tumor suppressor gene driving malignant mesothelioma

Mitchell Cheung, Joseph R. Testa

Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation

Jonathan E. Schoenhals, Steven N. Seyedin, Clark Anderson, Eric D. Brooks, Yun R. Li, Ahmed I. Younes, Sharareh Niknam, Ailin Li, Hampartsoum B. Barsoumian, Maria Angelica Cortez, James W. Welsh

Diagnostic and prognostic biomarkers for malignant mesothelioma: an update

Zhongjian Chen, Giovanni Gaudino, Harvey I. Pass, Michele Carbone, Haining Yang

Immunotherapy for malignant pleural mesothelioma: current status and future directions

Jordan Dozier, Hua Zheng, Prasad S. Adusumilli

Biology and clinical significance of circulating tumor cell subpopulations in lung cancer

Linda O’Flaherty, Harriet Wikman, Klaus Pantel

Routine clinical use of circulating tumor cells for diagnosis of mutations and chromosomal rearrangements in non-small cell lung cancer—ready for prime-time?

Emma Pailler, Vincent Faugeroux, Marianne Oulhen, Cyril Catelain, Françoise Farace

Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer

Sumitra Mohan, Francesca Chemi, Ged Brady

Biophysical technologies for understanding circulating tumor cell biology and metastasis

Derrick W. Su, Jorge Nieva

Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer

Marianna Gallo, Antonella De Luca, Monica Rosaria Maiello, Amelia D’Alessio, Claudia Esposito, Nicoletta Chicchinelli, Laura Forgione, Maria Carmela Piccirillo, Gaetano Rocco, Alessandro Morabito, Gerardo Botti, Nicola Normanno

Integrating immunotherapy into chemoradiation regimens for medically inoperable locally advanced non-small cell lung cancer

Salma K. Jabbour, Abigail T. Berman, Charles B. Simone II

Editorial

An alternative way to initiate Notch1 signaling in non-small cell lung cancer

Yi-Lin Yang, David Jablons, Liang You

Combination MET- and EGFR-directed therapy in MET-overexpressing non-small cell lung cancers: time to move on to better biomarkers?

Fernando C. Santini, Siddharth Kunte, Alexander Drilon

Systematic Review and Meta-analysis

Association of the metformin with the risk of lung cancer: a meta-analysis

Li Wang, Yong Song, Guan-Nan Wu, Dong-Mei Yuan

China Lung Cancer Research Highlight

Dll4/Notch1 signaling from tip/stalk endothelial cell specification to stroma-dependent lung tumor inhibition: a flavor of Dll4/Notch1 pleiotropy in tumor cell biology

Maria Felice Brizzi, Paola Defilippi

Editorials

Dulanermin in cancer therapy: Still much to do

Cristina Quintavalle, Gerolama Condorelli

Review Articles

EGFR molecular testing in African-American non-small cell lung cancer patients - a review of discrepant data

Bradley T. Clifford, Pingfu Fu, Nathan A. Pennell, Balazs Halmos, Rom S. Leidner

Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung

Pedro Mendez, Jose Luis Ramirez

Role of HGF/MET axis in resistance of lung cancer to contemporary management

Kanwal Pratap Singh Raghav, Ana Maria Gonzalez-Angulo, George R. Blumenschein Jr

Circulating soluble intercellular adhesion Molecule-1 in lung cancer: a systematic review

Xiaoling Gu, Chunyan Ma, Dongmei Yuan, Yong Song

Ceritinib

Clinical development and approval of second generation ALK inhibitors for ALK rearranged lung cancer

Daniel B. Costa

Onartuzumab plus erlotinib

Targeting MET in NSCLC: looking for a needle in a haystack

Lorenza Landi, Federico Cappuzzo

Nivolumab

Nivolumab (anti-PD-1, BMS-936558, ONO-4538) in patients with advanced non-small cell lung cancer

Arun Rajan, James L. Gulley

Brief Report

The role of Imaging and Radiation Oncology Core for precision medicine era of clinical trial

Ying Xiao, Mark Rosen

Review Article on Update on Pathology and Predictive Biomarkers of Lung Cancer

Biology of invasive mucinous adenocarcinoma of the lung

Yoon Jin Cha, Hyo Sup Shim

Immunohistochemistry for predictive biomarkers in non-small cell lung cancer

Mari Mino- Kenudson

Below are the latest Translational Lung Cancer Research articles published online ahead of print publication.

Currently no content available!

Journal Highlight more

Translational Lung Cancer Research is an international, peer-reviewed, open-access journal indexed by Science Citation Index Expanded (SCIE) and PubMed/PubMed Central, focusing on cutting-edge development on the transition from preclinical to clinical research, including but not limited to multimodality therapy, markers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to lung cancer and relevant thoracic diseases.